Back to News
Market Impact: 0.36

Halvårsrapport : januari - juni 2026

HMNKF
Corporate EarningsCompany FundamentalsTechnology & InnovationESG & Climate PolicyBanking & LiquidityCredit & Bond Markets
Halvårsrapport : januari - juni 2026

HMS rapporterade ett rekordstarkt kvartal: orderingången steg 20% till 979 MSEK och nettoomsättningen ökade 18% till 991 MSEK. EBITA ökade till 266 MSEK (marginal 26,8%, upp från 19,8%), och resultat efter skatt uppgick till 155 MSEK (vinst per aktie 3,10 SEK). Kassaflödet från löpande verksamhet stärktes till 334 MSEK och nettoskulden sjönk till 1,74x (från 3,12x), men bolaget varnar för stigande minnespriser och längre ledtider som kan belasta bruttomarginalen under H2.

Analysis

HMS is benefiting from a rare combination of end-market strength and product criticality: when datacenter and semiconductor capex are rising, the comms/control layer becomes a small-cost, high-urgency line item, which usually supports pricing power and faster backlog conversion. That makes the business less cyclical than the headline industrial exposure suggests, and the stronger cash generation gives management more room to buy growth rather than just harvest it. The strategic stakes in AI look more like optionality than near-term earnings, but they can deepen OEM relationships and raise switching costs over time.

The main near-term risk is not demand; it is supply-chain inflation. Memory and component lead times rising into H2 can create a delayed margin hit even if orders stay healthy, because it forces either higher input costs, more inventory, or shipment slippage. That kind of squeeze is usually what knocks down high-quality industrial names after a strong print: the market extrapolates gross margin durability until the next quarter proves otherwise. Falsifier to the bullish view is simple: if organic order growth decelerates sharply in Q3 or gross margin gives back most of the recent expansion, the rerating case breaks.

Contrarian take: the market may be underweighting how much balance-sheet repair and FCF convert this into a platform for accretive M&A, especially after the Molex integration broadens product reach. The consensus likely treats the quarter as a clean beat; I think the more important signal is that HMS is moving into a higher-quality earnings profile with less leverage and more strategic flexibility. That argues for owning weakness, not chasing the first pop.